title: Transcranial direct stimulation and fluoxetine for the treatment of depression.
authors.forename: Sergio P
authors.initials: SP
authors.lastname: Rigonatti
authors.forename: Paulo S
authors.initials: PS
authors.lastname: Boggio
authors.forename: Martin L
authors.initials: ML
authors.lastname: Myczkowski
authors.forename: Emma
authors.initials: E
authors.lastname: Otta
authors.forename: Juliana T
authors.initials: JT
authors.lastname: Fiquer
authors.forename: Rafael B
authors.initials: RB
authors.lastname: Ribeiro
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nitsche
authors.forename: Alvaro
authors.initials: A
authors.lastname: Pascual-Leone
authors.forename: Felipe
authors.initials: F
authors.lastname: Fregni
mesh_terms: D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010555:Personality Inventory / Q000706:statistics & numerical data; D017397:Prefrontal Cortex / Q000502:physiology*; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D050781:Transcranial Magnetic Stimulation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors